Jim Simons Assembly Biosciences, Inc. Transaction History

Renaissance Technologies LLC

$56.7 Billion
Q2 2024

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 13, 2024	SELL	$0.65 - $1.25 $41,063 - $78,967	-63,174 Reduced 12.8%	430,517 $353,000
Q3 2023 Nov 14, 2023	SELL	$0.87 - $1.13 $177,748 - $230,869	-204,309 Reduced 29.27%	493,691 $437,000
Q2 2023 Aug 11, 2023	SELL	$0.81 - $1.15 $54,918 - $77,970	-67,800 Reduced 8.85%	698,000 $803,000
Q1 2023 May 12, 2023	BUY	$0.8 - $1.74 $209,932 - $456,603	262,416 Added 52.13%	765,800 $644,000
Q4 2022 Feb 13, 2023	BUY	$1.09 - $20.4 $241,090 - $4.51 Million	221,184 Added 78.38%	503,384 $654,000
Q3 2022 Nov 14, 2022	BUY	$1.7 - $20.52 $93,330 - $1.13 Million	54,900 Added 24.15%	282,200 $463,000
Q2 2022 Aug 12, 2022	BUY	$1.35 - $2.29 $123,390 - $209,306	91,400 Added 67.26%	227,300 $477,000
Q1 2022 May 13, 2022	SELL	$1.46 - $2.45 $781,279 - $1.31 Million	-535,123 Reduced 79.75%	135,900 $280,000
Q4 2021 Feb 11, 2022	BUY	$2.13 - $3.46 $1.15 Million - $1.87 Million	540,423 Added 413.8%	671,023 $1.56 Million
Q3 2021 Nov 12, 2021	SELL	$3.14 - $3.9 $707,256 - $878,439	-225,241 Reduced 63.3%	130,600 $454,000
Q2 2021 Aug 13, 2021	SELL	$3.8 - $4.56 $841,677 - $1.01 Million	-221,494 Reduced 38.36%	355,841 $1.38 Million
Q1 2021 May 13, 2021	BUY	$4.33 - $6.63 $767,860 - $1.18 Million	177,335 Added 44.33%	577,335 $2.66 Million
Q4 2020 Feb 10, 2021	BUY	$4.87 - $17.29 $1.53 Million - $5.42 Million	313,714 Added 363.57%	400,000 $2.42 Million
Q3 2020 Nov 13, 2020	BUY	$15.08 - $27.04 $281,151 - $504,133	18,644 Added 27.56%	86,286 $1.42 Million
Q2 2020 Aug 13, 2020	BUY	$14.57 - $23.96 $230,220 - $378,591	15,801 Added 30.48%	67,642 $1.58 Million
Q1 2020 May 14, 2020	SELL	$10.27 - $21.23 $1.56 Million - $3.23 Million	-152,300 Reduced 74.61%	51,841 $769,000
Q4 2019 Feb 13, 2020	BUY	$8.36 - $23.81 $661,694 - $1.88 Million	79,150 Added 63.32%	204,141 $4.18 Million
Q3 2019 Nov 13, 2019	SELL	$9.83 - $14.82 $81,677 - $123,139	-8,309 Reduced 6.23%	124,991 $1.23 Million
Q2 2019 Aug 12, 2019	BUY	$12.9 - $20.8 $1.33 Million - $2.14 Million	102,900 Added 338.49%	133,300 $1.8 Million
Q1 2019 May 14, 2019	SELL	$17.7 - $24.93 $223,020 - $314,118	-12,600 Reduced 29.3%	30,400 $599,000
Q4 2018 Feb 13, 2019	BUY	$19.05 - $36.45 $819,150 - $1.57 Million	43,000 New	43,000 $973,000

Others Institutions Holding ASMB

# of Institutions

Shares Held

16.3K

Call Options Held

Put Options Held

ETF Managers Group, LLC Summit, NJ

16.3K
Shares

$277,028
0.0% of portfolio

View Full List

About ASSEMBLY BIOSCIENCES, INC.

Ticker ASMB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 48,436,900
Market Cap $822M
Description
Assembly Biosciences, Inc., a clinical-stage biotechnology company, discovers and develops therapeutic candidates for the treatment of hepatitis B virus (HBV) infection in the United States. The company's lead product candidate is Vebicorvir, which as completed Phase 2 clinical trials to treat patients with chronic HBV infection. It is also deve...

More about ASMB

Track Jim Simons's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Renaissance Technologies LLC, based on Form 13F filings with the SEC.

News

Stay updated on Renaissance Technologies LLC and Jim Simons with notifications on news.

Account